Your browser doesn't support javascript.
loading
ACT001 inhibited CD133 transcription by targeting and inducing Olig2 ubiquitination degradation.
Deng, Huiting; Liu, Hailin; Yang, Guoyue; Wang, Dandan; Luo, Ying; Li, Chenglong; Qi, Zhenchang; Liu, Zhili; Wang, Peng; Jia, Yanfang; Gao, Yingtang; Ding, Yahui.
Afiliação
  • Deng H; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Liu H; State Key Laboratory of Medicinal Chemical Biology, College of Chemistry, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin, 300353, People's Republic of China.
  • Yang G; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, People's Republic of China.
  • Wang D; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Luo Y; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Li C; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Qi Z; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Liu Z; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Wang P; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Jia Y; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Gao Y; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
  • Ding Y; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease, Tianjin Third Central Hospital affiliated to Nankai University, Nankai University, 83 Jintang Road, Tianjin, 300170, People
Oncogenesis ; 12(1): 19, 2023 Mar 30.
Article em En | MEDLINE | ID: mdl-36990974

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncogenesis Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncogenesis Ano de publicação: 2023 Tipo de documento: Article